期刊文献+

胎儿生长受限患者胎盘组织中松弛素受体的表达 被引量:1

Expression of relaxin receptor in placental tissues of normal pregnancy and fetal growth restriction.
原文传递
导出
摘要 目的探讨胎儿生长受限(FGR)患者胎盘组织中松弛素受体LGR7表达与胎儿生长受限发病的关系。方法应用链霉菌抗生物素蛋白-过氧化物酶连接法和RT-PCR技术检测40例正常孕妇(正常组)及40例胎儿生长受限组(FGR组)胎盘组织中松弛素受体LGR7及mRNA的表达。结果(1)两组孕妇的胎盘组织中均有松弛素受体LGR7表达,主要定位于胎盘绒毛滋养细胞的细胞膜上,在细胞滋养细胞、合体滋养细胞中都有较高的表达水平。(2)正常组胎盘组织中松弛素受体LGR7蛋白的表达水平为0.928±0.002,FGR组为0.620±0.022,两组比较,差异有统计学意义(P<0.01)。(3)正常组胎盘组织中松弛素受体LGR7mRNA表达水平为0.780±0.021,FGR组组为0.414±0.032,两组比较,差异有统计学意义(P<0.01)。结论FGR患者胎盘组织中松弛素受体表达水平下降,可能与FGR的发病有关。 Objective: To study the location and level of relaxin receptor in placenta tissues of preeclampsia and normal pregnancy, and the relationship of relaxin receptor with fetal growth restriction (FGR) . Methods: Forty placenta tissue samples from pregnant women with FGR (study group), and 40 samples from normal pregnancies (control group) were obtained. We detected the expression of relaxin receptor by immunohistochemistry and the expression of relaxin receptor mRNA by RT - PCR. Results : In the placenta of control and FGR groups, the leucine - rich repeat - containing G protein - coupled receptor ( LGR7 ) was positively expressed. Relaxin receptor was located in the membrane of trophoblast cells. There were both strong signals on cytotrophoblastic ceils and syneytiotrophoblast. The level of relaxin receptor in the control group was 0. 928 ± 0. 002, and 0. 620 ± 0. 022 in FGR group. Thedifference between the two groups was obvious ( P 〈0. 01 ) . In the control group, the level of relaxin receptor mRNA was 0. 780 ± 0. 021 ; in FGR group, it was 0. 414 ± 0. 032. The difference was obvious ( P 〈 0. 01 ) . Conclusion: Decrease in the expression of relaxin receptor at placenta is related with the occurrence and development of FGR.
出处 《中国优生与遗传杂志》 2010年第3期83-85,共3页 Chinese Journal of Birth Health & Heredity
关键词 胎儿生长迟缓 胎盘 受体 G-蛋白偶联 Fetal growth retardation Placenta Receptors, G - protein - coupled
  • 相关文献

参考文献8

  • 1Rynolds RM, Phillips DL Long - term consequence of intrauterine growth retarfation [ J ]. Horm Res, 1998,49 : 28 - 31.
  • 2Barker DJ. The long -term outcome of retarded fetal growth[ J]. Clin Obstet Gynecol, 1997,40:853 - 863.
  • 3Agardh E, Herbst A, Aberg A, et al. Fetal growth is not associated with early onset retinopathy in type 1 diabetes[ J]. Diabetes Res Clin Pract ,2000,48:61 - 65.
  • 4Mazer boury S, Bouley DM, Sudo S, et al. Leuine - rich repeat - containing,Gprotein- Coupled receptor 4 null mice exhibit intrauterine growth retardation associated with embyonie and perinatal lethality [ J]. Mol Endocrnol,2004 ,18 :2241.
  • 5Bathgate RA, Siebel AL, Tovote P, et al. Purification and characteri - Zation. Of relaxin from the tammar wallaby and expression in corpus Lutem[ J]. Biol Reprod ,2002,67:293 - 300.
  • 6Iveu R, Einspanier A. Relaxin peptides are new globe players [ J ]. Trends Endocrinol Metab, 2002,13:343 - 348.
  • 7Bryant - Greenwood GD, Schwabe C. Human relaxins : chemistry and biology[J]. Docr Endocr Rev, 1994,15:5 -26.
  • 8闻良珍,熊锦文.胎儿宫内发育迟缓的病理生理变化[J].中国实用妇科与产科杂志,2002,18(1):19-20. 被引量:58

共引文献57

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部